A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We deliver transformative solutions that power real results. See how we can help.
Optimizing Supply Chain
Maximizing Value-Based Care
Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.
Guided by our values, our employees work every day to make meaningful differences in healthcare. At the core of what we do is our most valuable resource - our people. Learn more about us.
Board of Directors
Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.
Find Out How
Collective purchasing power lowers costs across your organization.
Intelligence plus unparalleled analytics equals data-driven solutions.
It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.
Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.
A voice for better healthcare policy is a voice for you.
Working closely with our members, we’re developing products and services to solve your most complex challenges.
Lower costs, greater efficiencies and a healthier bottom line.
Proven practices that result in better outcomes.
Intersecting specialty drugs with better management and data-driven best practices.
Controlling your future with integrated care delivery practices.
More savings and ROI is a win-win.
Data diving to deliver insights you can act on.
Supporting healthcare transformation through the generation of real-world evidence.
Working closely with our members, we're developing products and services to solve your most complex challenges.
Our most recent insights, articles and more, all in one place.
View Our Latest
Discover what leading healthcare providers are achieving through Premier membership.
Stay informed with our white papers, webinars and e-books.
Browse our blog for a taste of what’s new and what’s next in healthcare.
Premier’s perspectives have been solicited by nationally renowned publications. Read on.
Read Premier’s latest announcements.
Catch our policy statements and perspectives on the latest in DC.
Compelling stories from the front lines of America’s health systems.
The proactive, predictive and behind-the-scenes insights you need to stay ahead in healthcare delivered monthly to your inbox.
A resource hub for all things Premier.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
Episode 50: Moonshots and healthcare. Why a radical approach is needed to save healthcare. When it comes to innovation, look no further than the...
Deena Shakir chats with Jonathan Slotkin, Chief Medical Officer at Contigo, and Kaycee Kalpin, Chief Marketing Officer at Premier Inc., to discuss her career journey...
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
New challenges call for new thinking. Premier and its members, will continue to innovate in the sustainability space in the months and years to come.
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Financial Times |
Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
Mike Alkire and Diana Brainard, SVP and Virology Therapeutic Area Head at Gilead, talk about launching a new therapy during COVID-19.